WebNov 12, 2024 · Catalyst plans to focus its resources on its complement therapeutics and protease medicines platform. The Company also reported its operating and financial results for the third quarter ended ... Web2 days ago · Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and …
Catalyst Biosciences Completes First Steps in Reverse
WebWe would like to show you a description here but the site won’t allow us. WebFeb 9, 2024 · BEVERLY, Mass. & LONDON-- ( BUSINESS WIRE )-- Akston Biosciences, which develops new classes of biologic therapeutics, today announced it has signed licensing, … tedima gmbh
Facing setbacks for months and an activist attack, Catalyst Biosciences …
WebCATALYST BIOSCIENCES AKTIE und aktueller Aktienkurs. Nachrichten zur Aktie Catalyst Biosciences Inc Registered Shs A2DLUK CBIO US14888D2080 WebSep 1, 2024 · Catalyst Biosciences, Inc. Announces September 21, 2024 as the Ex-Dividend Date for Special Cash Dividend of $1.43 per share WebJob opportunities at Catalyst Biosciences. As an equal opportunity employer, Catalyst values and cultivates diversity, inclusion and belonging in the workplace. tedi magdeburg